• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管主动脉瓣置换术治疗重度主动脉瓣狭窄的中期结果和血流动力学表现:St Jude Medical Epic 主动脉生物瓣的评估

Mid-term outcomes and hemodynamic performance of the St Jude Medical Epic aortic bioprosthesis for severe aortic stenosis.

机构信息

Department of Cardiovascular Surgery, Hyogo Prefectural Amagasaki General Medical Center, 2-17-77, Higashinaniwa-Cho, Amagasaki, Hyogo, 660-8550, Japan.

出版信息

J Artif Organs. 2024 Jun;27(2):125-130. doi: 10.1007/s10047-023-01405-z. Epub 2023 Jun 8.

DOI:10.1007/s10047-023-01405-z
PMID:37291209
Abstract

The St. Jude Medical Epic Supra valve is a porcine bioprosthesis designed for complete supraannular implantation. No report has shown the hemodynamic performance and clinical outcomes of aortic valve replacement with the Epic Supra valve for severe aortic stenosis in a Japanese cohort. We retrospectively evaluated 65 patients who underwent aortic valve replacement using the Epic Supra valve for aortic stenosis at our department between May, 2011 and October, 2016. The mean follow-up period was 68.7 ± 32.7 months, and the follow-up rate was 89.2%. The mean age was 76.8 ± 5.3 years. The 1-, 5-, and 8-year survival rates were 96.9%, 79.4%, and 60.3%, respectively. The rates of freedom from valve-related events were 96.6% and 81.9% at 5 and 8 years, respectively. Four patients were diagnosed with structural valve deterioration (SVD), and reintervention was performed in two patients. The rates of freedom from SVD were 98.2% and 83.3% at 5 and 8 years, respectively, and the mean time to diagnosis of SVD was 72.5 ± 25.3 months. The mean pressure gradient (MPG) was 16.8 ± 6.0 mmHg postoperatively, 17.5 ± 9.4 mmHg at 5 years, and 21.2 ± 12.4 mmHg at 8 years (p = 0.08). The effective orifice area index (EOAI) was 0.95 ± 0.2 cm2/m2 immediately after surgery, 0.96 ± 0.27 cm2/m2 at 5 years, and 0.84 ± 0.2 cm2/m2 at 8 years (p = 0.10). An increase in MPG and decrease in EOAI were also observed, which may be associated with SVD. Follow-up after 5 years is important to determine if there is an increase.

摘要

圣犹达医疗公司 Epic Supra 瓣膜是一种猪生物瓣,设计用于完全瓣上植入。目前尚无报道显示 Epic Supra 瓣膜在日本队列中用于严重主动脉瓣狭窄的主动脉瓣置换的血流动力学性能和临床结果。我们回顾性评估了 2011 年 5 月至 2016 年 10 月期间在我院因主动脉瓣狭窄接受 Epic Supra 瓣膜主动脉瓣置换术的 65 例患者。平均随访时间为 68.7±32.7 个月,随访率为 89.2%。平均年龄为 76.8±5.3 岁。1、5 和 8 年的生存率分别为 96.9%、79.4%和 60.3%。5 年和 8 年时瓣膜相关事件无复发率分别为 96.6%和 81.9%。4 例诊断为结构性瓣膜退化(SVD),其中 2 例再次介入治疗。5 年和 8 年时瓣膜无 SVD 复发率分别为 98.2%和 83.3%,SVD 的平均诊断时间为 72.5±25.3 个月。术后平均压力梯度(MPG)为 16.8±6.0mmHg,5 年时为 17.5±9.4mmHg,8 年时为 21.2±12.4mmHg(p=0.08)。术后即刻有效瓣口面积指数(EOAI)为 0.95±0.2cm2/m2,5 年时为 0.96±0.27cm2/m2,8 年时为 0.84±0.2cm2/m2(p=0.10)。MPG 升高和 EOAI 降低也观察到,这可能与 SVD 有关。5 年后的随访对于确定是否有增加是很重要的。

相似文献

1
Mid-term outcomes and hemodynamic performance of the St Jude Medical Epic aortic bioprosthesis for severe aortic stenosis.经导管主动脉瓣置换术治疗重度主动脉瓣狭窄的中期结果和血流动力学表现:St Jude Medical Epic 主动脉生物瓣的评估
J Artif Organs. 2024 Jun;27(2):125-130. doi: 10.1007/s10047-023-01405-z. Epub 2023 Jun 8.
2
The St Jude Medical Trifecta aortic pericardial valve: results from a global, multicenter, prospective clinical study.圣犹达医疗三尖瓣主动脉心包瓣:一项全球性、多中心、前瞻性临床研究结果。
J Thorac Cardiovasc Surg. 2014 Feb;147(2):590-7. doi: 10.1016/j.jtcvs.2012.12.087. Epub 2013 Mar 7.
3
Long-term valve performance of St Jude Medical Epic porcine bioprosthesis in aortic position.圣犹达医疗 Epic 猪生物瓣在主动脉瓣位置的长期瓣膜性能。
J Artif Organs. 2024 Jun;27(2):131-137. doi: 10.1007/s10047-023-01401-3. Epub 2023 Apr 26.
4
Comprehensive hemodynamic performance and frequency of patient-prosthesis mismatch of the St. Jude Medical Trifecta bioprosthetic aortic valve.圣犹达医疗Trifecta生物人工主动脉瓣的综合血流动力学性能及患者-人工瓣膜不匹配发生率
J Heart Valve Dis. 2014 Jul;23(4):516-23.
5
The Toronto root stentless valve in the subcoronary position is hemodynamically superior to the mosaic stented completely supra-annular bioprosthesis.置于冠状动脉下位置的多伦多无支架瓣膜在血流动力学上优于镶嵌式带支架完全瓣环上生物假体。
J Heart Valve Dis. 2005 Nov;14(6):814-21; discussion 821.
6
[Clinical and hemodynamic results of the mosaic bioprosthesis in aortic position].[主动脉位置镶嵌式生物假体的临床及血流动力学结果]
Z Kardiol. 2003 May;92(5):407-14. doi: 10.1007/s00392-003-0927-2.
7
Comprehensive hemodynamic comparison and frequency of patient-prosthesis mismatch between the St. Jude Medical Trifecta and Epic Bioprosthetic aortic valves.圣犹达医疗Trifecta主动脉瓣与Epic生物人工主动脉瓣之间的全面血流动力学比较及患者-人工瓣膜不匹配的发生率
J Am Soc Echocardiogr. 2014 Jun;27(6):581-9. doi: 10.1016/j.echo.2014.01.002. Epub 2014 Feb 15.
8
Long-Term Outcome of the Sorin Freedom SOLO Stentless Aortic Valve.索林自由SOLO无支架主动脉瓣的长期结果
J Heart Valve Dis. 2016 Nov;25(6):679-684.
9
Early hemodynamic performance of the Trifecta™ surgical bioprosthesis aortic valve in Indian patient population: 12 month outcomes of the EVEREST post-market study.Trifecta™ 外科生物人工心脏主动脉瓣膜在印度患者群体中的早期血流动力学表现:EVEREST 上市后研究的 12 个月结果
J Cardiothorac Surg. 2018 Sep 25;13(1):96. doi: 10.1186/s13019-018-0783-9.
10
Suture technique does not affect hemodynamic performance of the small supra-annular Trifecta bioprosthesis.缝合技术不影响小瓣环上Trifecta生物假体的血流动力学性能。
J Thorac Cardiovasc Surg. 2014 Oct;148(4):1347-51. doi: 10.1016/j.jtcvs.2013.12.006. Epub 2014 Jan 2.

本文引用的文献

1
Comparison of Long-term Performance of Bioprosthetic Aortic Valves in Sweden From 2003 to 2018.2003 年至 2018 年瑞典生物瓣主动脉瓣的长期性能比较。
JAMA Netw Open. 2022 Mar 1;5(3):e220962. doi: 10.1001/jamanetworkopen.2022.0962.
2
Structural valve deterioration after aortic valve replacement with the Trifecta valve.经 Trifecta 瓣膜置换术后的主动脉瓣结构性瓣膜衰败。
Interact Cardiovasc Thorac Surg. 2021 Jan 1;32(1):39-46. doi: 10.1093/icvts/ivaa236.
3
Midterm results after St Jude Medical Epic porcine xenograft for aortic, mitral, and double valve replacement.
圣犹达医疗公司Epic猪异种移植物用于主动脉瓣、二尖瓣和双瓣膜置换后的中期结果。
J Card Surg. 2020 Aug;35(8):1769-1777. doi: 10.1111/jocs.14554. Epub 2020 Jun 29.
4
Reintervention After Aortic Valve Replacement: Comparison of 3 Aortic Bioprostheses.主动脉瓣置换术后再次干预:3 种主动脉生物瓣的比较。
Ann Thorac Surg. 2020 Aug;110(2):615-621. doi: 10.1016/j.athoracsur.2019.10.060. Epub 2019 Dec 14.
5
Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).评估经导管和外科主动脉生物瓣膜长期耐久性时结构恶化和瓣膜功能衰竭的标准化定义:欧洲经皮心血管介入协会(EAPCI)的共识声明,得到欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)认可
Eur J Cardiothorac Surg. 2017 Sep 1;52(3):408-417. doi: 10.1093/ejcts/ezx244.
6
Twenty-Seven-Year Experience With the St. Jude Medical Biocor Bioprosthesis in the Aortic Position.
Ann Thorac Surg. 2015 Dec;100(6):2220-6. doi: 10.1016/j.athoracsur.2015.06.027. Epub 2015 Oct 1.
7
The effect of postoperative medical treatment on left ventricular mass regression after aortic valve replacement.主动脉瓣置换术后药物治疗对左心室质量消退的影响。
J Thorac Cardiovasc Surg. 2015 Mar;149(3):781-6. doi: 10.1016/j.jtcvs.2014.10.034. Epub 2014 Oct 15.
8
Hemodynamic performance of the St. Jude Medical Epic Supra aortic stented valve.圣犹达医疗公司Epic主动脉弓上带支架瓣膜的血流动力学性能。
J Heart Valve Dis. 2011 May;20(3):327-31.
9
St Jude Medical Epic porcine bioprosthesis: results of the regulatory evaluation.圣犹达医疗 Epic 猪生物瓣:监管评估结果。
J Thorac Cardiovasc Surg. 2011 Jun;141(6):1449-54.e2. doi: 10.1016/j.jtcvs.2010.05.055. Epub 2011 Feb 1.
10
Postoperative left ventricular mass regression after aortic valve replacement for aortic stenosis.主动脉瓣置换术后主动脉瓣狭窄患者左心室质量的术后逆转。
Ann Thorac Surg. 2010 Mar;89(3):745-50. doi: 10.1016/j.athoracsur.2009.12.034.